新冠住院后长新冠的炎症特征及与1年恢复的关联:英国前瞻性观察研究
PHOSP-COVID前瞻性队列研究纳入英国新冠住院出院成人,评估5个月和1年恢复情况。5个月聚类分析显示非常严重和伴认知障碍中度集群炎症介质升高,包括IL-6。
要点
- 女性、肥胖和有创机械通气与1年完全恢复可能性低独立相关。
- 非常严重和伴认知障碍中度集群炎症介质升高,IL-6在两者中均升高。
核心结论
- 新冠住院出院1年后多健康领域后遗症显著,少数患者感觉完全恢复。
- 患者感知健康相关生活质量较住院前下降,1年时仍低于病前。
- 系统性炎症和肥胖是潜在可治疗特征,值得进一步临床试验。
研究设计与样本
- PHOSP-COVID为前瞻性纵向队列研究,招募英国新冠住院出院成人(≥18岁)。
主要发现
- 聚类分析(n=1636)确认四个集群:非常严重、严重、伴认知障碍中度、轻度。
- 非常严重和伴认知障碍中度集群较轻度集群组织损伤和修复炎症介质升高,IL-6在两者中均升高(n=626)。
临床怎么用
- 对新冠住院出院患者应关注1年时多健康领域后遗症,不能仅以完全恢复为预期。
- 女性、肥胖和有创机械通气患者恢复可能性更低,需加强随访和康复支持。
- 系统性炎症和肥胖可作为潜在治疗靶点,但需临床试验验证。
局限性
- 恢复评估基于患者报告结局,部分指标为回顾性评估。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: No effective pharmacological or non-pharmacological interventions exist for patients with long COVID. We aimed to describe recovery 1 year after hospital discharge for COVID-19, identify factors associated with patient-perceived recovery, and identify potential therapeutic targets by describing the underlying inflammatory profiles of the previously described recovery clusters at 5 months after hospital discharge. METHODS: The Post-hospitalisation COVID-19 study (PHOSP-COVID) is a prospective, longitudinal cohort study recruiting adults (aged ≥18 years) discharged from hospital with COVID-19 across the UK. Recovery was assessed using patient-reported outcome measures, physical performance, and organ function at 5 months and 1 year after hospital discharge, and stratified by both patient-perceived recovery and recovery cluster. Hierarchical logistic regression modelling was performed for patient-perceived recovery at 1 year. Cluster analysis was done using the clustering large applications k-medoids approach using clinical outcomes at 5 months. Inflammatory protein profiling was analysed from plasma at the 5-month visit. This study is registered on the ISRCTN Registry, ISRCTN10980107, and recruitment is ongoing. FINDINGS: 2320 participants discharged from hospital between March 7, 2020, and April 18, 2021, were assessed at 5 months after discharge and 807 (32·7%) participants completed both the 5-month and 1-year visits. 279 (35·6%) of these 807 patients were women and 505 (64·4%) were men, with a mean age of 58·7 (SD 12·5) years, and 224 (27·8%) had received invasive mechanical ventilation (WHO class 7-9). The proportion of patients reporting full recovery was unchanged between 5 months (501 [25·5%] of 1965) and 1 year (232 [28·9%] of 804). Factors associated with being less likely to report full recovery at 1 year were female sex (odds ratio 0·68 [95% CI 0·46-0·99]), obesity (0·50 [0·34-0·74]) and invasive mechanical ventilation (0·42 [0·23-0·76]). Cluster analysis (n=1636) corroborated the previously reported four clusters: very severe, severe, moderate with cognitive impairment, and mild, relating to the severity of physical health, mental health, and cognitive impairment at 5 months. We found increased inflammatory mediators of tissue damage and repair in both the very severe and the moderate with cognitive impairment clusters compared with the mild cluster, including IL-6 concentration, which was increased in both comparisons (n=626 participants). We found a substantial deficit in median EQ-5D-5L utility index from before COVID-19 (retrospective assessment; 0·88 [IQR 0·74-1·00]), at 5 months (0·74 [0·64-0·88]) to 1 year (0·75 [0·62-0·88]), with minimal improvements across all outcome measures at 1 year after discharge in the whole cohort and within each of the four clusters. INTERPRETATION: The sequelae of a hospital admission with COVID-19 were substantial 1 year after discharge across a range of health domains, with the minority in our cohort feeling fully recovered. Patient-perceived health-related quality of life was reduced at 1 year compared with before hospital admission. Systematic inflammation and obesity are potential treatable traits that warrant further investigation in clinical trials. FUNDING: UK Research and Innovation and National Institute for Health Research.
引用
- Clinical characteristics with inflammation profiling of long COVID and association with 1-year recovery following hospitalisation in the UK: a prospective observational study. Lancet Respir Med. 2022. PMID: 35472304. doi:10.1016/S2213-2600(22)00127-8
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。